Cerebral blood flow regulation

Cerebral blood flow regulation refers to the ensemble of physiological processes that maintain stable delivery of oxygen and nutrients to brain tissue despite fluctuations in systemic arterial pressure. This involves several overlapping regulatory systems: – Autoregulation by myogenic responses in arterioles, – Vascular reactivity mediated by endothelial factors like nitric oxide, – Metabolic control responding primarily to CO₂ levels, – Neurogenic influences through perivascular nerves. Key cellular players include endothelial cells producing vasoactive mediators; astrocytes facilitating neurovascular coupling; smooth muscle cells adjusting vessel diameter; and neurons signaling metabolic demand. Disruption in these regulatory systems contributes significantly to neurological diseases including stroke, dementia related to small vessel disease, orthostatic intolerance syndromes, and cognitive impairment associated with chronic hypertension or diabetes. Because this term does not denote a unique molecular entity but rather an integrated networked function across many targets/pathways within the cerebrovasculature and neural tissue itself, it should be considered outside the scope for direct drug targeting unless specifying one component mechanism.

Other names

Cerebral autoregulationCBF regulationNeurovascular coupling (as one component)Control of cerebral blood flow

Mechanisms are diverse depending on the drug class and include: Modulation of vascular smooth muscle tone via ion channels or G protein-coupled receptors. Alteration in production/action of vasoactive substances like nitric oxide, prostaglandins, endothelins. Influence on metabolic byproducts such as CO₂ sensitivity.